
The zzso Cancer Quality of Life zzso zzso has been developed to be a standardized assessment instrument to assess systematically pediatric cancer patient's zzso quality of life zzso zzso zzso serial measurement of pediatric cancer patients' zzso in Phase III zzso controlled clinical trials is increasingly being recognized as an essential component in evaluating the comprehensive health outcomes of modern zzso treatment zzso The zzso zzso short form was zzso derived from the zzso long form zzso zzso which was administered to zzso pediatric cancer patients and their parents during various stages of zzso The feasibility zzso of missing values per zzso and range of measurement zzso of minimum zzso zzso and maximum zzso zzso possible zzso was calculated for the five zzso scales and the total scale zzso zzso for the zzso was very good, with less than zzso missing zzso Range of measurement was full, with no ceiling effects zzso zzso and low to moderate floor effects zzso zzso The zzso demonstrated very good feasibility and range of zzso In its short form, the zzso is practical for Phase III clinical zzso Future studies will test the utility of the zzso as a brief serial measure for monitoring the zzso outcomes for children and adolescents with zzso 

